10.21.25 -- 10 Ways To Strengthen U.S. API: Part II

Effective precision weighing systems enable users to balance product throughput, center distance, and standard deviation. Explore key considerations in this technology's development and weighing methods.

The updated E2500-25 standard transforms pharmaceutical manufacturing with a proactive, risk-based approach, enhancing compliance and accelerating the delivery of therapies to patients.

Antibody-drug conjugates' manufacturing supply chain contains five different technologies with specific asset needs: monoclonal antibody, cytotoxic payload, linker, bioconjugation, and fill & finish.

Learn how EU GMP Annex 1 (2022) redefines cleanroom air monitoring standards and emphasizes continuous viable sampling in Grade A and B environments to ensure aseptic integrity and compliance.

The greatest challenge in drug development can be finding a team capable of carrying a molecule through complexities. Discover three considerations that build a foundation for partnership.

The rising incidence and severity of obesity have amplified a therapeutic need in healthcare. Read more about Dr. Srinivasan Shanmugam discussing the challenges and impact of GLP-1 analogs.

Filtration removes contaminants to ensure safety and is essential in various applications, from lab-scale tasks to GMP production. Examine how its simplicity and reliability make it indispensable.

Innovative nasal drug delivery strategies can unlock faster, patient-friendly therapeutic solutions by combining smart formulation, advanced testing platforms, and rigorous preclinical evaluation.

Uncover a screening process to quickly assess HME feasibility that yields more accurate predictions for API loading and degradation while saving material and time compared to traditional approaches.

Gain insight into a breakthrough in analytical performance that delivers unmatched precision, faster results, and reduced waste. This innovation sets a new standard for sustainable analysis.

Modulated DSC addresses challenges in material characterization, which enables precise analysis of glass transitions and overlapping transitions to enhance insights beyond standard DSC.

Find out how a CDMO with integrated services enabled a botanical drug start-up to commence its Phase 1 clinical trial, paving the way for further advancement of its innovative botanical drug.

See how a partnership with SCC helped launch a biomanufacturing program to build career pathways and community talent for Spokane’s growing life sciences and pharmaceutical manufacturing sector.